• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合抗 PD-1 和抗逆转录病毒疗法可提供针对 SIV 的治疗益处。

Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.

机构信息

Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.

Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

出版信息

JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.122940.

DOI:10.1172/jci.insight.122940
PMID:30232277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237231/
Abstract

Therapeutic strategies that augment antiviral immunity and reduce the viral reservoir are critical to achieving durable remission of HIV. The coinhibitory receptor programmed death-1 (PD-1) regulates CD8+ T cell dysfunction during chronic HIV and SIV infections. We previously demonstrated that in vivo blockade of PD-1 during chronic SIV infection improves the function of antiviral CD8+ T cells and B cells. Here, we tested the immunological and virological effects of PD-1 blockade combined with antiretroviral therapy (ART) in rhesus macaques. Administration of anti-PD-1 antibody 10 days prior to ART initiation rapidly enhanced antiviral CD8+ T cell function and diminished IFN-stimulated genes. This resulted in faster viral suppression in plasma and better Th17 cell reconstitution in the rectal mucosa following ART initiation. PD-1 blockade during ART resulted in lower levels of cell-associated replication-competent virus. Following ART interruption, PD-1 antibody-treated animals showed markedly higher expansion of proliferating CXCR5+perforin+granzyme B+ effector CD8+ T cells and lower regulatory T cells that resulted in better control of viremia. Our results show that PD-1 blockade can be administered safely with ART to augment antiviral CD8+ T cell function and reduce the viral reservoir, leading to improved control of viral rebound after ART interruption.

摘要

增强抗病毒免疫和减少病毒储存库的治疗策略对于实现 HIV 的持久缓解至关重要。共抑制受体程序性死亡受体-1(PD-1)调节慢性 HIV 和 SIV 感染期间 CD8+T 细胞的功能障碍。我们之前证明,在慢性 SIV 感染期间体内阻断 PD-1 可改善抗病毒 CD8+T 细胞和 B 细胞的功能。在这里,我们测试了 PD-1 阻断联合抗逆转录病毒疗法(ART)在恒河猴中的免疫和病毒学效应。在开始 ART 之前 10 天给予抗 PD-1 抗体可迅速增强抗病毒 CD8+T 细胞的功能并减少 IFN 刺激基因。这导致在开始 ART 后更快地抑制血浆中的病毒,并更好地重建直肠黏膜中的 Th17 细胞。ART 期间的 PD-1 阻断导致细胞相关复制型病毒的水平降低。ART 中断后,接受 PD-1 抗体治疗的动物表现出明显更高的增殖性 CXCR5+穿孔素+颗粒酶 B+效应 CD8+T 细胞的扩增和较低的调节性 T 细胞,从而更好地控制病毒血症。我们的结果表明,PD-1 阻断可与 ART 一起安全地给药,以增强抗病毒 CD8+T 细胞的功能并减少病毒储存库,从而改善 ART 中断后病毒反弹的控制。

相似文献

1
Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.联合抗 PD-1 和抗逆转录病毒疗法可提供针对 SIV 的治疗益处。
JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.122940.
2
In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit.在体阻断程序性细胞死亡-1 通路使用可溶性重组 PD-1-Fc 增强 CD4+ 和 CD8+ T 细胞反应,但临床获益有限。
J Immunol. 2013 Dec 15;191(12):6060-70. doi: 10.4049/jimmunol.1302044. Epub 2013 Nov 13.
3
Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.抗逆转录病毒治疗中断后,PD-1 阻断在慢性感染猴免疫缺陷病毒的恒河猴治疗性疫苗接种中加剧艾滋病进展。
J Virol. 2022 Feb 9;96(3):e0178521. doi: 10.1128/JVI.01785-21. Epub 2021 Nov 24.
4
PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.ART 中断后 PD-1 阻断增强了对恒河猴致病性 SIV 的控制。
Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2202148119. doi: 10.1073/pnas.2202148119. Epub 2022 Aug 8.
5
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.CTLA-4 和 PD-1 双重阻断会导致 SIV 重新激活,而在中断抗逆转录病毒治疗后无法控制反弹。
Nat Med. 2020 Apr;26(4):519-528. doi: 10.1038/s41591-020-0782-y. Epub 2020 Mar 16.
6
Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.在恒河猴感染猴免疫缺陷病毒的急性期阻断干扰素α后,慢性淋巴细胞活化减少。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.01760-17. Print 2018 May 1.
7
Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.CD8β 耗竭联合白细胞介素-15 超激动剂 N-803 诱导感染猴免疫缺陷病毒、长期接受抗逆转录病毒治疗的恒河猴病毒激活。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00755-20.
8
Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.猴免疫缺陷病毒阻断 ART 后病毒学和免疫学特征
J Virol. 2020 Jul 1;94(14). doi: 10.1128/JVI.00338-20.
9
CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.在接受短期抗逆转录病毒治疗的感染猴免疫缺陷病毒(SIV)的猕猴中,维持病毒抑制需要CD8(+)淋巴细胞。
Immunity. 2016 Sep 20;45(3):656-668. doi: 10.1016/j.immuni.2016.08.018.
10
CTLA-4PD-1 Memory CD4 T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques.CTLA-4和PD-1记忆性CD4 T细胞在接受抗逆转录病毒治疗但SIV感染的恒河猴体内对病毒持续存在起关键作用。
Immunity. 2017 Oct 17;47(4):776-788.e5. doi: 10.1016/j.immuni.2017.09.018.

引用本文的文献

1
Understanding the HIV-specific T-cell response to immune checkpoint blockade: what can we learn from cancer immunotherapy?了解HIV特异性T细胞对免疫检查点阻断的反应:我们能从癌症免疫治疗中学到什么?
Curr Opin HIV AIDS. 2025 Sep 1;20(5):441-448. doi: 10.1097/COH.0000000000000957. Epub 2025 Jul 18.
2
CCR5 gene editing and HIV immunotherapy: current understandings, challenges, and future directions.CCR5基因编辑与HIV免疫疗法:当前认知、挑战及未来方向
Front Immunol. 2025 Jun 18;16:1590690. doi: 10.3389/fimmu.2025.1590690. eCollection 2025.
3
Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+ T cells.早期治疗和PD1抑制可增强滤泡性CD8+ T细胞的HIV特异性功能。
JCI Insight. 2025 Apr 8;10(7):e180309. doi: 10.1172/jci.insight.180309.
4
Immune checkpoint inhibitors in infectious disease.传染病中的免疫检查点抑制剂。
Immunol Rev. 2024 Nov;328(1):350-371. doi: 10.1111/imr.13388. Epub 2024 Sep 9.
5
HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.HIV 免疫无应答者的特征是广泛的免疫衰老和受损的淋巴细胞细胞因子产生能力。
Front Immunol. 2024 May 8;15:1350065. doi: 10.3389/fimmu.2024.1350065. eCollection 2024.
6
Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection.通过阻断TIGIT实现的免疫恢复不足以控制慢性猴免疫缺陷病毒感染。
J Virol. 2024 Jun 13;98(6):e0027324. doi: 10.1128/jvi.00273-24. Epub 2024 May 22.
7
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection.探讨 HIV 感染中的慢性炎症、免疫代谢和 T 细胞功能障碍。
Viruses. 2024 Jan 31;16(2):219. doi: 10.3390/v16020219.
8
An angel or a devil? Current view on the role of CD8 T cells in the pathogenesis of myasthenia gravis.天使还是恶魔?CD8 T 细胞在重症肌无力发病机制中的作用的当前观点。
J Transl Med. 2024 Feb 20;22(1):183. doi: 10.1186/s12967-024-04965-7.
9
Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV.免疫检查点抑制剂作为逆转 T 细胞耗竭和逆转 HIV 潜伏的潜在治疗方法,用于 HIV 感染者。
Front Immunol. 2023 Dec 7;14:1270881. doi: 10.3389/fimmu.2023.1270881. eCollection 2023.
10
GITR activation impairs CD8 T cell function in people with HIV on antiretroviral therapy.在接受抗逆转录病毒治疗的HIV感染者中,糖皮质激素诱导的肿瘤坏死因子受体(GITR)激活会损害CD8 T细胞功能。
iScience. 2023 Nov 2;26(11):108165. doi: 10.1016/j.isci.2023.108165. eCollection 2023 Nov 17.

本文引用的文献

1
Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.免疫检查点阻断恢复 HIV 特异性 CD4 T 细胞对 NK 细胞的辅助作用。
J Immunol. 2018 Aug 1;201(3):971-981. doi: 10.4049/jimmunol.1701551. Epub 2018 Jun 22.
2
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency.程序性细胞死亡蛋白-1 有助于 HIV-1 潜伏的建立和维持。
AIDS. 2018 Jul 17;32(11):1491-1497. doi: 10.1097/QAD.0000000000001849.
3
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy.TLR7 激动剂可诱导 SIV 感染的恒河猴在抗逆转录病毒治疗时短暂的病毒血症,并减少病毒储存库。
Sci Transl Med. 2018 May 2;10(439). doi: 10.1126/scitranslmed.aao4521.
4
The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.抗半胱天冬酶抑制剂 Q-VD-OPH 可预防 SIV 感染恒河猴的艾滋病疾病进展。
J Clin Invest. 2018 Apr 2;128(4):1627-1640. doi: 10.1172/JCI95127. Epub 2018 Mar 19.
5
Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.将“潜伏”HIV 消灭于“震杀”之中:策略探讨
Cell Host Microbe. 2018 Jan 10;23(1):14-26. doi: 10.1016/j.chom.2017.12.004.
6
Mechanisms of resistance to immune checkpoint inhibitors.免疫检查点抑制剂耐药的机制。
Br J Cancer. 2018 Jan;118(1):9-16. doi: 10.1038/bjc.2017.434. Epub 2018 Jan 2.
7
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.肠道微生物组影响基于 PD-1 的免疫疗法对上皮性肿瘤的疗效。
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
8
CTLA-4PD-1 Memory CD4 T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques.CTLA-4和PD-1记忆性CD4 T细胞在接受抗逆转录病毒治疗但SIV感染的恒河猴体内对病毒持续存在起关键作用。
Immunity. 2017 Oct 17;47(4):776-788.e5. doi: 10.1016/j.immuni.2017.09.018.
9
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.用于癌症免疫治疗的PD-1和PD-L1检查点信号抑制:机制、联合应用及临床结果
Front Pharmacol. 2017 Aug 23;8:561. doi: 10.3389/fphar.2017.00561. eCollection 2017.
10
Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.HIV-1感染巨噬细胞中干扰素刺激基因诱导的机制。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.00744-17. Print 2017 Oct 15.